Facebook Linkedin Twitter
Inside Precision Medicine Cullinan Nets $280M Investment and Targets CD19 in Lupus

Late-stage clinical drug development

immune system
News & Features

Cullinan Nets $280M Investment and Targets CD19 in Lupus

0
Bladder Cancer
News & Features

Researchers Learn Why Cisplatin-Based Chemotherapy Works Best in Advanced Bladder Cancer

Alice McCarthy
0
Cell Research, Pipetting sample into a petri dish of cells in the lab
Learning Labs

Spheroids vs. Organoids—A Data-Driven Approach for 3D Culture Model Selection

0
Bowel cancer
News & Features

Bioprinted Bowel Cancer Spheroids Poised to Advance Targeted Treatments

0
antibodies
News & Features

CDMO Services: Enabling Faster Time to Results and Market

0
Virus with RNA molecule inside. Viral variant concept. 3D rendered illustration.
Coronavirus

Amilorides Offer New Anti-Viral Mechanism to Target COVID-19

0
3d illustration of a cancer cell in the process of mitosis
News & Features

Droplets That Regulate Chromatin Structure Play Role in Cancer Development

0
life science professionals
Molecular Dx

Sponsored: Is your assay sustainable?

0
Picture of a DNA spiral with a piece being removed by a hand holding tweezers to represent genome editing
News & Features

Early Data for Editas’ CRISPR Therapy Shows Efficacy “Signals” in Two Patients

0
ArcherDx and Illumina to Partner, Co-Market In Vitro Diagnostics
Molecular Dx

ArcherDx and Illumina to Partner, Co-Market In Vitro Diagnostics

0
123...7Page 1 of 7

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine